,
de Groot, Stefanie
Pijl, Hanno
Charehbili, Ayoub
van de Ven, Saskia
Smit, Vincent T. H. B. M.
Meershoek-Klein Kranenbarg, Elma
Heijns, Joan B.
van Warmerdam, Laurence J. C.
Kessels, Lonneke W.
Dercksen, M. Wouter
Pepels, Manon J. A. E.
van Laarhoven, Hanneke W. M.
Vriens, Birgit E. P. J.
Putter, Hein
Fiocco, Marta
Liefers, Gerrit-Jan
van der Hoeven, Jacobus J. M.
Nortier, Johan W. R.
Kroep, Judith R.
Funding for this research was provided by:
dutch cancer society (2010-4682)
Amgen
Sanofi (n.a.)
Amgen Nederland (n.a.)
Article History
Received: 25 April 2019
Accepted: 31 July 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: The study (NCT01099436) was conducted in accordance with the Declaration of Helsinki (October 2008) and was approved by the Ethics Committee of the LUMC in agreement with the Dutch law for medical research involving human subjects.
: Not applicable.
: The authors declare that they have no competing interests.